0000899243-23-016904.txt : 20230705
0000899243-23-016904.hdr.sgml : 20230705
20230705164653
ACCESSION NUMBER: 0000899243-23-016904
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230620
FILED AS OF DATE: 20230705
DATE AS OF CHANGE: 20230705
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Reilly Thomas Charles
CENTRAL INDEX KEY: 0001827590
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21392
FILM NUMBER: 231069977
MAIL ADDRESS:
STREET 1: C/O CARA THERAPEUTICS, INC.
STREET 2: 4 STAMFORD PLAZA, 107 ELM STREET
CITY: STAMFORD
STATE: CT
ZIP: 06902
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMARIN CORP PLC\UK
CENTRAL INDEX KEY: 0000897448
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: SPACES SOUTH DOCKLANDS, BLOCK C
STREET 2: 77 SIR JOHN ROGERSON'S QUAY
CITY: DUBLIN 2
STATE: L2
ZIP: D02 VK60
BUSINESS PHONE: 353 1 6699 020
MAIL ADDRESS:
STREET 1: SPACES SOUTH DOCKLANDS, BLOCK C
STREET 2: 77 SIR JOHN ROGERSON'S QUAY
CITY: DUBLIN 2
STATE: L2
ZIP: D02 VK60
FORMER COMPANY:
FORMER CONFORMED NAME: AMARIN PHARMACEUTICALS PLC
DATE OF NAME CHANGE: 20000201
FORMER COMPANY:
FORMER CONFORMED NAME: ETHICAL HOLDINGS PLC
DATE OF NAME CHANGE: 19930322
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-06-20
0
0000897448
AMARIN CORP PLC\UK
AMRN
0001827590
Reilly Thomas Charles
C/O AMARIN PHARMA, INC.
440 US HIGHWAY 22
BRIDGEWATER
NJ
08807
0
1
0
0
SVP and CFO
0
Ordinary Shares
2023-07-01
4
M
0
16667
A
33584
D
Ordinary Shares
2023-07-01
4
F
0
8209
1.19
D
25375
D
Restricted Stock Units
0.00
2023-07-01
4
M
0
16667
0.00
D
Ordinary Shares
16667
33333
D
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
On February 21, 2023, the Issuer's Remuneration Committee of its Board of Directors certified the achievement of certain performance metrics for this Restricted Stock Unit ("RSU") award, resulting in the grant of 50,000 RSUs scheduled to vest in three equal installments on each of the first, second and third anniversary of the grant date of July 1, 2022, subject to the Reporting Person's continued service to the Issuer.
Not applicable.
Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities.
Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion.
By: /s/ Thomas Charles Reilly
2023-07-05